 | • レポートコード：MRC2-11QY01753 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はインスリンデテミルのグローバル市場について調査・分析したレポートです。種類別（再利用可能、使い捨て）市場規模、用途別（病院、診療所、家庭用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インスリンデテミルの競争状況、市場シェア ・世界のインスリンデテミル市場：種類別市場規模 2015年-2020年（再利用可能、使い捨て） ・世界のインスリンデテミル市場：種類別市場規模予測 2021年-2026年（再利用可能、使い捨て） ・世界のインスリンデテミル市場：用途別市場規模 2015年-2020年（病院、診療所、家庭用、その他） ・世界のインスリンデテミル市場：用途別市場規模予測 2021年-2026年（病院、診療所、家庭用、その他） ・北米のインスリンデテミル市場分析：米国、カナダ ・ヨーロッパのインスリンデテミル市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインスリンデテミル市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインスリンデテミル市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインスリンデテミル市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novo Nordisk、MNKD、Bristol-Myers Squibb Company、Emisphere、Biocon ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Insulin Detemir Market
The global Insulin Detemir market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Insulin Detemir Scope and Market Size
Insulin Detemir market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Detemir market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Insulin Detemir market is segmented into
Resuable
Disposable
Segment by Application, the Insulin Detemir market is segmented into
Hospital
Clinic
Home Use
Others
Regional and Country-level Analysis
The Insulin Detemir market is analysed and market size information is provided by regions (countries).
The key regions covered in the Insulin Detemir market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Insulin Detemir Market Share Analysis
Insulin Detemir market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Insulin Detemir business, the date to enter into the Insulin Detemir market, Insulin Detemir product introduction, recent developments, etc.
The major vendors covered:
Novo Nordisk
MNKD
Bristol-Myers Squibb Company
Emisphere
Biocon
…
1 Study Coverage
1.1 Insulin Detemir Product Introduction
1.2 Market Segments
1.3 Key Insulin Detemir Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Insulin Detemir Market Size Growth Rate by Type
1.4.2 Resuable
1.4.3 Disposable
1.5 Market by Application
1.5.1 Global Insulin Detemir Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Use
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Insulin Detemir Market Size, Estimates and Forecasts
2.1.1 Global Insulin Detemir Revenue 2015-2026
2.1.2 Global Insulin Detemir Sales 2015-2026
2.2 Global Insulin Detemir, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Insulin Detemir Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Insulin Detemir Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Insulin Detemir Competitor Landscape by Players
3.1 Insulin Detemir Sales by Manufacturers
3.1.1 Insulin Detemir Sales by Manufacturers (2015-2020)
3.1.2 Insulin Detemir Sales Market Share by Manufacturers (2015-2020)
3.2 Insulin Detemir Revenue by Manufacturers
3.2.1 Insulin Detemir Revenue by Manufacturers (2015-2020)
3.2.2 Insulin Detemir Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Insulin Detemir Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Insulin Detemir Revenue in 2019
3.2.5 Global Insulin Detemir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Insulin Detemir Price by Manufacturers
3.4 Insulin Detemir Manufacturing Base Distribution, Product Types
3.4.1 Insulin Detemir Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insulin Detemir Product Type
3.4.3 Date of International Manufacturers Enter into Insulin Detemir Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Insulin Detemir Market Size by Type (2015-2020)
4.1.1 Global Insulin Detemir Sales by Type (2015-2020)
4.1.2 Global Insulin Detemir Revenue by Type (2015-2020)
4.1.3 Insulin Detemir Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Insulin Detemir Market Size Forecast by Type (2021-2026)
4.2.1 Global Insulin Detemir Sales Forecast by Type (2021-2026)
4.2.2 Global Insulin Detemir Revenue Forecast by Type (2021-2026)
4.2.3 Insulin Detemir Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Insulin Detemir Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Insulin Detemir Market Size by Application (2015-2020)
5.1.1 Global Insulin Detemir Sales by Application (2015-2020)
5.1.2 Global Insulin Detemir Revenue by Application (2015-2020)
5.1.3 Insulin Detemir Price by Application (2015-2020)
5.2 Insulin Detemir Market Size Forecast by Application (2021-2026)
5.2.1 Global Insulin Detemir Sales Forecast by Application (2021-2026)
5.2.2 Global Insulin Detemir Revenue Forecast by Application (2021-2026)
5.2.3 Global Insulin Detemir Price Forecast by Application (2021-2026)
6 North America
6.1 North America Insulin Detemir by Country
6.1.1 North America Insulin Detemir Sales by Country
6.1.2 North America Insulin Detemir Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Insulin Detemir Market Facts & Figures by Type
6.3 North America Insulin Detemir Market Facts & Figures by Application
7 Europe
7.1 Europe Insulin Detemir by Country
7.1.1 Europe Insulin Detemir Sales by Country
7.1.2 Europe Insulin Detemir Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Insulin Detemir Market Facts & Figures by Type
7.3 Europe Insulin Detemir Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Insulin Detemir by Region
8.1.1 Asia Pacific Insulin Detemir Sales by Region
8.1.2 Asia Pacific Insulin Detemir Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Insulin Detemir Market Facts & Figures by Type
8.3 Asia Pacific Insulin Detemir Market Facts & Figures by Application
9 Latin America
9.1 Latin America Insulin Detemir by Country
9.1.1 Latin America Insulin Detemir Sales by Country
9.1.2 Latin America Insulin Detemir Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Insulin Detemir Market Facts & Figures by Type
9.3 Central & South America Insulin Detemir Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Insulin Detemir by Country
10.1.1 Middle East and Africa Insulin Detemir Sales by Country
10.1.2 Middle East and Africa Insulin Detemir Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Insulin Detemir Market Facts & Figures by Type
10.3 Middle East and Africa Insulin Detemir Market Facts & Figures by Application
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description and Business Overview
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Insulin Detemir Products Offered
11.1.5 Novo Nordisk Related Developments
11.2 MNKD
11.2.1 MNKD Corporation Information
11.2.2 MNKD Description and Business Overview
11.2.3 MNKD Sales, Revenue and Gross Margin (2015-2020)
11.2.4 MNKD Insulin Detemir Products Offered
11.2.5 MNKD Related Developments
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Corporation Information
11.3.2 Bristol-Myers Squibb Company Description and Business Overview
11.3.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bristol-Myers Squibb Company Insulin Detemir Products Offered
11.3.5 Bristol-Myers Squibb Company Related Developments
11.4 Emisphere
11.4.1 Emisphere Corporation Information
11.4.2 Emisphere Description and Business Overview
11.4.3 Emisphere Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Emisphere Insulin Detemir Products Offered
11.4.5 Emisphere Related Developments
11.5 Biocon
11.5.1 Biocon Corporation Information
11.5.2 Biocon Description and Business Overview
11.5.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biocon Insulin Detemir Products Offered
11.5.5 Biocon Related Developments
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description and Business Overview
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Insulin Detemir Products Offered
11.1.5 Novo Nordisk Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Insulin Detemir Market Estimates and Projections by Region
12.1.1 Global Insulin Detemir Sales Forecast by Regions 2021-2026
12.1.2 Global Insulin Detemir Revenue Forecast by Regions 2021-2026
12.2 North America Insulin Detemir Market Size Forecast (2021-2026)
12.2.1 North America: Insulin Detemir Sales Forecast (2021-2026)
12.2.2 North America: Insulin Detemir Revenue Forecast (2021-2026)
12.2.3 North America: Insulin Detemir Market Size Forecast by Country (2021-2026)
12.3 Europe Insulin Detemir Market Size Forecast (2021-2026)
12.3.1 Europe: Insulin Detemir Sales Forecast (2021-2026)
12.3.2 Europe: Insulin Detemir Revenue Forecast (2021-2026)
12.3.3 Europe: Insulin Detemir Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Insulin Detemir Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Insulin Detemir Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Insulin Detemir Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Insulin Detemir Market Size Forecast by Region (2021-2026)
12.5 Latin America Insulin Detemir Market Size Forecast (2021-2026)
12.5.1 Latin America: Insulin Detemir Sales Forecast (2021-2026)
12.5.2 Latin America: Insulin Detemir Revenue Forecast (2021-2026)
12.5.3 Latin America: Insulin Detemir Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Insulin Detemir Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Insulin Detemir Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Insulin Detemir Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Insulin Detemir Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Insulin Detemir Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Insulin Detemir Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Insulin Detemir Market Segments
Table 2. Ranking of Global Top Insulin Detemir Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Detemir Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Resuable
Table 5. Major Manufacturers of Disposable
Table 6. Global Insulin Detemir Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 7. Global Insulin Detemir Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 8. Global Insulin Detemir Sales by Regions 2015-2020 (K Pcs)
Table 9. Global Insulin Detemir Sales Market Share by Regions (2015-2020)
Table 10. Global Insulin Detemir Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Insulin Detemir Sales by Manufacturers (2015-2020) (K Pcs)
Table 12. Global Insulin Detemir Sales Share by Manufacturers (2015-2020)
Table 13. Global Insulin Detemir Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Insulin Detemir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Detemir as of 2019)
Table 15. Insulin Detemir Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Insulin Detemir Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Insulin Detemir Price (2015-2020) (USD/Pcs)
Table 18. Insulin Detemir Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Insulin Detemir Product Type
Table 20. Date of International Manufacturers Enter into Insulin Detemir Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Insulin Detemir Sales by Type (2015-2020) (K Pcs)
Table 23. Global Insulin Detemir Sales Share by Type (2015-2020)
Table 24. Global Insulin Detemir Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Insulin Detemir Revenue Share by Type (2015-2020)
Table 26. Insulin Detemir Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 27. Global Insulin Detemir Sales by Application (2015-2020) (K Pcs)
Table 28. Global Insulin Detemir Sales Share by Application (2015-2020)
Table 29. North America Insulin Detemir Sales by Country (2015-2020) (K Pcs)
Table 30. North America Insulin Detemir Sales Market Share by Country (2015-2020)
Table 31. North America Insulin Detemir Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Insulin Detemir Revenue Market Share by Country (2015-2020)
Table 33. North America Insulin Detemir Sales by Type (2015-2020) (K Pcs)
Table 34. North America Insulin Detemir Sales Market Share by Type (2015-2020)
Table 35. North America Insulin Detemir Sales by Application (2015-2020) (K Pcs)
Table 36. North America Insulin Detemir Sales Market Share by Application (2015-2020)
Table 37. Europe Insulin Detemir Sales by Country (2015-2020) (K Pcs)
Table 38. Europe Insulin Detemir Sales Market Share by Country (2015-2020)
Table 39. Europe Insulin Detemir Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Insulin Detemir Revenue Market Share by Country (2015-2020)
Table 41. Europe Insulin Detemir Sales by Type (2015-2020) (K Pcs)
Table 42. Europe Insulin Detemir Sales Market Share by Type (2015-2020)
Table 43. Europe Insulin Detemir Sales by Application (2015-2020) (K Pcs)
Table 44. Europe Insulin Detemir Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Insulin Detemir Sales by Region (2015-2020) (K Pcs)
Table 46. Asia Pacific Insulin Detemir Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Insulin Detemir Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Insulin Detemir Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Insulin Detemir Sales by Type (2015-2020) (K Pcs)
Table 50. Asia Pacific Insulin Detemir Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Insulin Detemir Sales by Application (2015-2020) (K Pcs)
Table 52. Asia Pacific Insulin Detemir Sales Market Share by Application (2015-2020)
Table 53. Latin America Insulin Detemir Sales by Country (2015-2020) (K Pcs)
Table 54. Latin America Insulin Detemir Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Insulin Detemir Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Insulin Detemir Revenue Market Share by Country (2015-2020)
Table 57. Latin America Insulin Detemir Sales by Type (2015-2020) (K Pcs)
Table 58. Latin America Insulin Detemir Sales Market Share by Type (2015-2020)
Table 59. Latin America Insulin Detemir Sales by Application (2015-2020) (K Pcs)
Table 60. Latin America Insulin Detemir Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Insulin Detemir Sales by Country (2015-2020) (K Pcs)
Table 62. Middle East and Africa Insulin Detemir Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Insulin Detemir Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Insulin Detemir Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Insulin Detemir Sales by Type (2015-2020) (K Pcs)
Table 66. Middle East and Africa Insulin Detemir Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Insulin Detemir Sales by Application (2015-2020) (K Pcs)
Table 68. Middle East and Africa Insulin Detemir Sales Market Share by Application (2015-2020)
Table 69. Novo Nordisk Corporation Information
Table 70. Novo Nordisk Description and Major Businesses
Table 71. Novo Nordisk Insulin Detemir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 72. Novo Nordisk Product
Table 73. Novo Nordisk Recent Development
Table 74. MNKD Corporation Information
Table 75. MNKD Description and Major Businesses
Table 76. MNKD Insulin Detemir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. MNKD Product
Table 78. MNKD Recent Development
Table 79. Bristol-Myers Squibb Company Corporation Information
Table 80. Bristol-Myers Squibb Company Description and Major Businesses
Table 81. Bristol-Myers Squibb Company Insulin Detemir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Bristol-Myers Squibb Company Product
Table 83. Bristol-Myers Squibb Company Recent Development
Table 84. Emisphere Corporation Information
Table 85. Emisphere Description and Major Businesses
Table 86. Emisphere Insulin Detemir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Emisphere Product
Table 88. Emisphere Recent Development
Table 89. Biocon Corporation Information
Table 90. Biocon Description and Major Businesses
Table 91. Biocon Insulin Detemir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Biocon Product
Table 93. Biocon Recent Development
Table 94. Global Insulin Detemir Sales Forecast by Regions (2021-2026) (K Pcs)
Table 95. Global Insulin Detemir Sales Market Share Forecast by Regions (2021-2026)
Table 96. Global Insulin Detemir Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 97. Global Insulin Detemir Revenue Market Share Forecast by Regions (2021-2026)
Table 98. North America: Insulin Detemir Sales Forecast by Country (2021-2026) (K Pcs)
Table 99. North America: Insulin Detemir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Europe: Insulin Detemir Sales Forecast by Country (2021-2026) (K Pcs)
Table 101. Europe: Insulin Detemir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Asia Pacific: Insulin Detemir Sales Forecast by Region (2021-2026) (K Pcs)
Table 103. Asia Pacific: Insulin Detemir Revenue Forecast by Region (2021-2026) (US$ Million)
Table 104. Latin America: Insulin Detemir Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Latin America: Insulin Detemir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Middle East and Africa: Insulin Detemir Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. Middle East and Africa: Insulin Detemir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Market Risks
Table 111. Main Points Interviewed from Key Insulin Detemir Players
Table 112. Insulin Detemir Customers List
Table 113. Insulin Detemir Distributors List
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Detemir Product Picture
Figure 2. Global Insulin Detemir Sales Market Share by Type in 2020 & 2026
Figure 3. Resuable Product Picture
Figure 4. Disposable Product Picture
Figure 5. Global Insulin Detemir Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Home Use
Figure 9. Others
Figure 10. Insulin Detemir Report Years Considered
Figure 11. Global Insulin Detemir Market Size 2015-2026 (US$ Million)
Figure 12. Global Insulin Detemir Sales 2015-2026 (K Pcs)
Figure 13. Global Insulin Detemir Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Insulin Detemir Sales Market Share by Region (2015-2020)
Figure 15. Global Insulin Detemir Sales Market Share by Region in 2019
Figure 16. Global Insulin Detemir Revenue Market Share by Region (2015-2020)
Figure 17. Global Insulin Detemir Revenue Market Share by Region in 2019
Figure 18. Global Insulin Detemir Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Insulin Detemir Revenue in 2019
Figure 20. Insulin Detemir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Insulin Detemir Sales Market Share by Type (2015-2020)
Figure 22. Global Insulin Detemir Sales Market Share by Type in 2019
Figure 23. Global Insulin Detemir Revenue Market Share by Type (2015-2020)
Figure 24. Global Insulin Detemir Revenue Market Share by Type in 2019
Figure 25. Global Insulin Detemir Market Share by Price Range (2015-2020)
Figure 26. Global Insulin Detemir Sales Market Share by Application (2015-2020)
Figure 27. Global Insulin Detemir Sales Market Share by Application in 2019
Figure 28. Global Insulin Detemir Revenue Market Share by Application (2015-2020)
Figure 29. Global Insulin Detemir Revenue Market Share by Application in 2019
Figure 30. North America Insulin Detemir Sales Growth Rate 2015-2020 (K Pcs)
Figure 31. North America Insulin Detemir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Insulin Detemir Sales Market Share by Country in 2019
Figure 33. North America Insulin Detemir Revenue Market Share by Country in 2019
Figure 34. U.S. Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.S. Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Insulin Detemir Market Share by Type in 2019
Figure 39. North America Insulin Detemir Market Share by Application in 2019
Figure 40. Europe Insulin Detemir Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. Europe Insulin Detemir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Insulin Detemir Sales Market Share by Country in 2019
Figure 43. Europe Insulin Detemir Revenue Market Share by Country in 2019
Figure 44. Germany Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Germany Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. France Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.K. Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Italy Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Russia Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Insulin Detemir Market Share by Type in 2019
Figure 55. Europe Insulin Detemir Market Share by Application in 2019
Figure 56. Asia Pacific Insulin Detemir Sales Growth Rate 2015-2020 (K Pcs)
Figure 57. Asia Pacific Insulin Detemir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Insulin Detemir Sales Market Share by Region in 2019
Figure 59. Asia Pacific Insulin Detemir Revenue Market Share by Region in 2019
Figure 60. China Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. China Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. South Korea Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. India Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Australia Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Taiwan Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Indonesia Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Thailand Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Malaysia Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Philippines Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Vietnam Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Insulin Detemir Market Share by Type in 2019
Figure 83. Asia Pacific Insulin Detemir Market Share by Application in 2019
Figure 84. Latin America Insulin Detemir Sales Growth Rate 2015-2020 (K Pcs)
Figure 85. Latin America Insulin Detemir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Insulin Detemir Sales Market Share by Country in 2019
Figure 87. Latin America Insulin Detemir Revenue Market Share by Country in 2019
Figure 88. Mexico Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Mexico Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Brazil Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Argentina Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Insulin Detemir Market Share by Type in 2019
Figure 95. Latin America Insulin Detemir Market Share by Application in 2019
Figure 96. Middle East and Africa Insulin Detemir Sales Growth Rate 2015-2020 (K Pcs)
Figure 97. Middle East and Africa Insulin Detemir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Insulin Detemir Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Insulin Detemir Revenue Market Share by Country in 2019
Figure 100. Turkey Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Turkey Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Saudi Arabia Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Insulin Detemir Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. U.A.E Insulin Detemir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Insulin Detemir Market Share by Type in 2019
Figure 107. Middle East and Africa Insulin Detemir Market Share by Application in 2019
Figure 108. North America Insulin Detemir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 109. North America Insulin Detemir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Insulin Detemir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. Europe Insulin Detemir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Insulin Detemir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Asia Pacific Insulin Detemir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Insulin Detemir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Latin America Insulin Detemir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Insulin Detemir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Middle East and Africa Insulin Detemir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
CISインスリンの世界市場（～2026年） Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body. Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government. Market Analysis and…- バイオシミラーインスリンの世界市場（～2026年） Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically significant differences in terms of safety and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference …
- インシュリン様成長因子Iの世界市場（～2026年） Market Analysis and Insights: Global Insulin Like Growth Factor I Market The global Insulin Like Growth Factor I market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Like Growth Factor I Scope and Market Size Insuli…
- インスリン有効成分の世界市場（～2026年） Market Analysis and Insights: Global Insulin Active Pharmaceutical Ingredient Market The global Insulin Active Pharmaceutical Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Active Pharmaceutical Ing…
- インスリン薬・デリバリー技術の世界市場（～2026年） Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along w…